Inhaled Drug Delivery
- Future needs for inhaled drug delivery
- Innovation in nebulized therapy
- Nebulizers – modern advances
- Development of propellant-free MDIs
- Aerosol-mediated delivery of drugs
- Triple combination inhalers – the challenges
- Functional respiratory imaging
Inhaled drug delivery is also termed as pulmonary drug delivery. It is the inhalation of drug formulation through the mouth and further deposition of the inhaled pharmacological agent in lower airways is the main purpose of this drug delivery rate. The inhalation therapies involved the use of leaves from plants, vapours from aromatic plants, balsams and myhrr. Delivery of drugs directly to the site of action reduces the dose needed to produce a pharmacological effect.
In recent years, the possibility of utilizing the pulmonary route for the systemic delivery of peptides and other molecules that are not absorbed through the gastrointestinal tract has also been explored.
- Future needs for inhaled drug delivery
- Innovation in nebulized therapy
- Nebulizers – modern advances
- Development of propellant-free MDIs
- Aerosol-mediated delivery of drugs
- Triple combination inhalers – the challenges
- Functional respiratory imaging
Committee Members
Vladlen Slepak
University of Miami School of Medicine, United States
Axel H Schonthal
University of Southern California, United States
Bernd Blobel
University of Regensburg, Germany
Consolato M Sergi
University of Alberta, Canada PDDS 2026 Speakers
Luis Jesus Villarreal Gomez
Universidad Autónoma de Baja California, Mexico
Lan Wang
Paretor LLC, United States
Maria Cristina Gamberini
University of Modena and Reggio Emilia, Italy
Lucas Amaral Machado
University of Sao Paulo State – UNESP, Brazil
Saad Tayyab
UCSI University, Malaysia
Anil Pareek
Anand Pharmacy College, IndiaSubmit your abstract Today
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil